An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
Study Identifier
P19-423
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
12+ years
Protocol Summary
Post-marketing surveillance study to evaluate the real world safety and effectiveness of Maviret (Glecaprevir/Pibrentasvir) administered under a normal, routine treatment practice by Korean patients with Chronic Hepatitis C Genotypes 1 to 6
Study Locations
Location
Status
Location
SoonChunHyang University CheonAn Hospital /ID# 209996
Cheonan-si, Chungcheongnam-do, Republic of Korea, 31151
Status
Not applicable
Location
Hallym University Sacred Heart Hospital /ID# 210809
Anyang, Gyeonggido, Republic of Korea, 14068
Status
Not applicable
Location
The Catholic University of Korea, Bucheon St.Mary's Hospital /ID# 216869
Bucheon-si, Gyeonggido, Republic of Korea, 14647
Status
Not applicable
Location
Dongguk University Ilsan Hospital /ID# 210609
Goyang, Gyeonggido, Republic of Korea, 10325
Status
Not applicable
Location
National health insurance Service ilsanhospital /ID# 209997
Goyang, Gyeonggido, Republic of Korea, 10444
Status
Not applicable
Location
SoonChunHyang University Buchon Hospital /ID# 210618
Habun, Gyeonggido, Republic of Korea, 14584
Status
Not applicable
Showing {first} - {last} of {total} Results